Skip to content

ARTELO BIOSCIENCES, INC.

ARTL

CIK 0001621221

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$11.67M
−31.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$26.13
+31.6% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$10.27M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
2.33M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings